Valeant Pharmaceuticals International Inc. Chief Executive Officer Michael Pearson is taking a medical leave of absence, putting management of the embattled drugmaker in the hands of a team of executives.
In a statement Monday, the company gave no update on the condition of Pearson, who was hospitalized last week with a severe case of pneumonia. The shares sank 8.7 percent to $104.14 at 10:16 a.m. in New York.
16:46 A look at how Trump’s moves on coal will affect the industry14
00:32 Elon Musk is setting up a company that will link brains and computers23
02:02 Trump taps Kushner to lead a SWAT team to fix government with business ideas29
18:04 With his presidency off course, Trump confronts the lessons of the health-care debacle26